192 related articles for article (PubMed ID: 10785593)
21. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
[TBL] [Abstract][Full Text] [Related]
26. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
Oda Y; Röse I; Radig K; Wagemann W; Mittler U; Roessner A
Virchows Arch; 1997 Feb; 430(2):99-105. PubMed ID: 9083512
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the classical MDR phenotype in epithelial ovarian carcinoma using primary cultures: a feasibility study.
Coley HM; Sargent JM; Williamson CJ; Titley J; Scheper RJ; Gregson SE; Elgie AW; Lewandowicz GM; Taylor CG
Anticancer Res; 2002; 22(1A):69-74. PubMed ID: 12017336
[TBL] [Abstract][Full Text] [Related]
28. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
Lehne G; Mørkrid L; den Boer M; Rugstad HE
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
Lehne G; Rugstad HE
Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
[TBL] [Abstract][Full Text] [Related]
30. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
31. In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.
Scott AM; Rosa E; Mehta BM; Divgi CR; Finn RD; Biedler JL; Tsuruo T; Kalaigian H; Larson SM
Nucl Med Biol; 1995 May; 22(4):497-504. PubMed ID: 7550027
[TBL] [Abstract][Full Text] [Related]
32. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.
Cagliero E; Ferracini R; Morello E; Scotlandi K; Manara MC; Buracco P; Comandone A; Baroetto Parisi R; Baldini N
Oncol Rep; 2004 Nov; 12(5):1023-31. PubMed ID: 15492788
[TBL] [Abstract][Full Text] [Related]
33. Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance.
Sparrow RL; Hall FJ; Siregar H; Van der Weyden MB
Leuk Res; 1993 Nov; 17(11):941-7. PubMed ID: 7901453
[TBL] [Abstract][Full Text] [Related]
34. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.
Larkin A; O'Driscoll L; Kennedy S; Purcell R; Moran E; Crown J; Parkinson M; Clynes M
Int J Cancer; 2004 Nov; 112(2):286-94. PubMed ID: 15352042
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
Damiani D; Michieli M; Ermacora A; Candoni A; Raspadori D; Geromin A; Stocchi R; Grimaz S; Masolini P; Michelutti A; Scheper RJ; Baccarani M
Haematologica; 1998 Apr; 83(4):290-7. PubMed ID: 9592977
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
Grogan TM; Spier CM; Salmon SE; Matzner M; Rybski J; Weinstein RS; Scheper RJ; Dalton WS
Blood; 1993 Jan; 81(2):490-5. PubMed ID: 8093668
[TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
38. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.
Herzog CE; Trepel JB; Mickley LA; Bates SE; Fojo AT
J Natl Cancer Inst; 1992 May; 84(9):711-6. PubMed ID: 1349044
[TBL] [Abstract][Full Text] [Related]
39. Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
Citti A; Boldrini R; Inserra A; Alisi A; Pessolano R; Mastronuzzi A; Zin A; De Sio L; Rosolen A; Locatelli F; Fruci D
Int J Oncol; 2012 Jul; 41(1):117-24. PubMed ID: 22504834
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Moiseeva NI; Laletina LA; Fetisov TI; Makhmudova LF; Manikaylo AE; Fomina LY; Burov DA; Lesovaya EA; Bokhyan BY; Zinovieva VY; Vilkova AS; Mekheda LV; Kozlov NA; Scherbakov AM; Kirilin EM; Belitsky GA; Yakubovskaya MG; Kirsanov KI
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]